A Certificate of Analysis (CoA) for a research-grade peptide is the primary document that links a specific lot of material to its analytical characterization. Researchers who cannot interpret CoA parameters correctly cannot make informed judgments about whether a peptide lot is appropriate for their experimental design. This review covers each CoA parameter in sequence, explains the analytical method behind it, states the standard acceptance specification for research use, and flags common deficiencies that indicate incomplete characterization.
Identity by Mass Spectrometry: What It Confirms and What It Does Not
MS identity confirmation by ESI-MS or MALDI-TOF reports the measured average molecular weight (AMW) of the peptide and compares it to the theoretical AMW calculated from the declared sequence. A match within ±0.5 Da (low-resolution instruments) or ±0.01 Da (high-resolution instruments) confirms that the predominant species in the sample has the expected molecular formula — but does not confirm amino acid sequence. Two peptides with the same sequence but different stereochemistry (L vs. D amino acids), or same sequence with a single deamidation (+1 Da), may or may not be distinguished depending on instrument resolution. Full sequence confirmation requires MS/MS fragmentation (b/y-ion assignment) or Edman degradation. A CoA reporting only "identity confirmed by MS" without specifying measured m/z values, charge states, and instrument resolution should be treated as incomplete identity documentation.
Purity by HPLC-UV: Method Context and Specification Limits
HPLC-UV purity represents the percentage of UV-absorbing material at 220 nm that elutes as the main peak, relative to all UV-absorbing peaks in the chromatogram. Standard research-grade specification is ≥98%; some applications accept ≥95% for complex peptides where synthesis yield limitations apply. Critical context: HPLC-UV purity does not detect non-UV-absorbing species. A peptide with 99% HPLC-UV purity may contain 5–15% water by mass (detected by Karl Fischer), inorganic salt counterion (detected by ion chromatography or ICP-MS), or residual organic solvents (detected by GC headspace). The HPLC-UV purity figure should therefore always be interpreted alongside the Karl Fischer result to understand the effective active-fraction content. For a lyophilized peptide with 98% HPLC-UV purity and 8% water content, the net active peptide fraction is approximately 98% × (1 - 0.08) = 90.2% of total mass — relevant to accurate molar dose calculations.
Endotoxin by Limulus Amebocyte Lysate (LAL): Specification and Significance
Endotoxin testing by LAL detects lipopolysaccharide (LPS) contamination derived from gram-negative bacterial cell walls — a common manufacturing contaminant in aqueous peptide solutions. The LAL kinetic turbidimetric method quantifies endotoxin in EU (endotoxin units) per mg of peptide. Standard specification for research-grade peptides intended for in vivo injection: ≤1 EU/mg. For in vitro cell culture applications, ≤5 EU/mg is generally acceptable, though inflammatory endpoint studies require ≤0.5 EU/mg or lower to prevent LPS-mediated NF-κB activation confounding cytokine readouts. A CoA without an endotoxin result is missing a critical safety and confound-control parameter for any bioassay application. Researchers should verify that the LAL method used is validated for interference with the specific peptide matrix — some charged peptides (poly-arginine sequences) can interfere with LAL kinetics and require peptide-specific interference control runs.
Water Content by Karl Fischer and Counterion Specification
Karl Fischer coulometric titration quantifies total water content (free and bound) in a lyophilized peptide. Specification ≤8% is standard for most lyophilized peptides, though hygroscopic sequences (high Arg, Lys, or Gly content) may absorb up to 12–15% water upon exposure to ambient humidity. High water content reduces the effective active fraction and can indicate incomplete lyophilization — a quality deficiency that also affects long-term storage stability. Counterion specification is frequently omitted from commercial CoAs, yet it is analytically and biologically significant. Peptides synthesized by SPPS and purified by HPLC in TFA-containing mobile phases carry TFA as the counterion. TFA (trifluoroacetate) is cytotoxic in cell culture systems at concentrations above approximately 0.5 mM. Ion exchange to acetate counterion is available from most manufacturers on request and should be specified for any peptide intended for cell culture use. CoA should explicitly state: salt form (TFA salt vs. acetate salt vs. free acid) and counterion content by ion chromatography or 19F NMR.
Interpreting a Complete CoA: Reference Checklist and Research Classification
A complete, research-grade CoA should include: peptide name and sequence, molecular formula and theoretical MW, lot number and manufacturing date, expiration date, storage conditions, identity result (measured m/z with instrument type specified), HPLC-UV purity (method parameters and chromatogram reference), endotoxin result (method and specification), water content (method and specification), counterion specification (form and content), and releasing QC analyst signature. Any CoA missing multiple of these elements should prompt the researcher to request supplementary data from the supplier before initiating experiments. These compounds are for research and laboratory use only. Not for unsupervised human consumption.